Dr. Acharya Balkrishna, a highly ascetic entrepreneur with a versatile personality, has published over 330 research articles in various national and international journals. His research interests include Ayurveda, agriculture, nanotechnology, and information technology. He holds several leadership positions, including the vice chancellor of the University of Patanjali, the chairman and MD of Patanjali Ayurved Ltd., and others.
Dr. Naveen Thakur obtained his Ph.D. in physics from Guru Nanak Dev University, Amritsar, India. He has more than 20 years' research experience. His research thrust areas include material science, green nanotechnology, and biomedical applications of nanomaterials. He is known for his passion for teaching both undergraduate and postgraduate students and training them as future scientists.
Dr. Vedpriya Arya obtained her Ph.D. in genetics from M.D. University Rohtak. She has worked extensively on integrating statistical and technological methods with plant-based medicines. She currently leads the Patanjali Herbal Research Department at the Patanjali Research Foundation and works on green nanotechnology-based approaches for the management of diseases.
Dr. Muralikrishnan Dhanasekaran is a professor in the Department of Drug Discovery and Development and a director of International Programs at Harrison School of Pharmacy, Auburn University, AL, USA.  He has teaching and research experience of over 25 years in the field of pharmacology and natural bioactives. His research mainly focuses on pharmacology and developing prophylactic and therapeutic strategies with synthetic drugs and natural bioactives to improve Global Healthcare.
Dr. Ashwani Kumar is a scientist C in the Herbal Research Department of the Patanjali Research Foundation and has a keen interest in the research areas of nanotechnology, probiotics, nutraceuticals, medicinal plants, and scientific writing. As a microbiologist, he focuses on the antimicrobial, antioxidant, and anticancer potential of green synthesized nanomaterials to combat drug resistance, oxidative stress, and cancer, respectively. Further, he is instrumental in studying the oxidative stress-mediated toxicity of nanomaterials, limiting their use in biological systems.